NHS National Generic Pharmaceuticals - Lenalidomide
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £70,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 18 Jul 2022 |
| Procedure | open |
| OCID | ocds-h6vhtk-02ee98 |
Awards (28)
This procurement was awarded to 14 suppliers. Values shown are per-award; the notice total is £70,000,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | £1 | 30 Aug 2022 | active |
| Accord-UK Ltd shared | · | · | active |
| Amarox Limited shared | £1 | 30 Aug 2022 | active |
| Amarox Limited shared | · | · | active |
| Bristol Myers Squibb shared | £1 | 30 Aug 2022 | active |
| Bristol Myers Squibb shared | · | · | active |
| Glenmark Pharmaceuticals Europe Limited shared | £1 | 30 Aug 2022 | active |
| Glenmark Pharmaceuticals Europe Limited shared | · | · | active |
| Mercury Pharmaceuticals Limited shared | £1 | 30 Aug 2022 | active |
| Mercury Pharmaceuticals Limited shared | · | · | active |
| Morningside Pharmaeuticals shared | £1 | 30 Aug 2022 | active |
| Morningside Pharmaeuticals shared | · | · | active |
| Mylan shared | £1 | 30 Aug 2022 | active |
| Mylan shared | · | · | active |
| Piramal Critical care Limited shared | £1 | 30 Aug 2022 | active |
| Piramal Critical care Limited shared | · | · | active |
| Ranbaxy UK shared | £1 | 30 Aug 2022 | active |
| Ranbaxy UK shared | · | · | active |
| Sandoz Ltd shared | £1 | 30 Aug 2022 | active |
| Sandoz Ltd shared | · | · | active |
| Teva UK Limited shared | £1 | 30 Aug 2022 | active |
| Teva UK Limited shared | · | · | active |
| Thornton and Ross Ltd shared | £1 | 30 Aug 2022 | active |
| Thornton and Ross Ltd shared | · | · | active |
| Wockhardt UK Limited shared | £1 | 30 Aug 2022 | active |
| Wockhardt UK Limited shared | · | · | active |
| Zentiva Pharma UK Ltd shared | £1 | 30 Aug 2022 | active |
| Zentiva Pharma UK Ltd shared | · | · | active |
description
NHS National Generic Pharmaceuticals- Lenalidomide<br/>Offer reference number: CM/PHG/21/5638<br/>Period of framework agreement: 01/09/2022 to 31/08/2023 (12 months) with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Lenalidomide:<br/>ALL REGIONS: 01/09/2022 to 31/08/2023 (12 months)
documents
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ifub/mAGXJN4oVQMk3K4wZeU3.XvN33NkOvLMe8dvNpSKqYw
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ifuc/Er1xBOFnzfXRP7HFHKcolTVNnC4KiIcWtNrLRwOqDis
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ifud/dy8hXTpy.Wdd8nJVClfiUd35rEiHuFU0zBNODfdTc5s
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Iful/OVF5NIR6x2ZzMr.MLULFYvDyLSW7Vp5pfRNqU050x7g
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IfuR/XQeCHGso50SxjtZTdSW4vttbjXWwvzAuEURt5oPCjfs
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IfuS/hi8dCbVftVvac5eQ.Cc_D0R9fhd7TSK9ALShvta0Irw
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IfuT/KmK9QvByJLe1B.On.U81buCiQ0yooDaWEkD3me3YS9Y
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IfuW/9qGdNc5GNyuhkAyO4pL3n5IZqIyJEUNn99JvPOkOJB8
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IfuX/nakwscMFYZEjJght_RgUgBdgWQCC..c0NwY3KEh0oUk
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IfuY/GAiUFauL4UQAwgxlKO3jXYvDA.SM7ptNgjz4AHhb28M
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IfuZ/SN_R9NA1rOQdhjDrkGQLufwcFdxb7qRYeSd2G3GiahM
- https://www.contractsfinder.service.gov.uk/Notice/24977041-d876-48e1-8cab-6da45cdeaae0 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
6 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 21 Oct 2021 | Prior information notice (F01) | Earlier regulations | 026411-2021 |
| 28 Jun 2022 | Contract notice (F02) | Earlier regulations | 017584-2022 |
| 28 Jun 2022 | Tender (tender) | · | 24977041-d876-48e1-8cab-6da45cdeaae0-549877 |
| 30 Sept 2022 | Contract award notice (F03) | Earlier regulations | 027452-2022 |
| 30 Sept 2022 | Award (award) | · | b76ce98c-f644-4e5a-af83-617f769811a4-576781 |
| 24 Feb 2023 | Planning (planning) | · | b8a2cbdf-9594-4f94-b3e0-77e7bc80cae1-618453 |
more from NHS England
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
- Multiple Sclerosis Management Service for Children - Contract Modification · 8 Jul 2026
- Foundation Pharmacist E-Portfolio · £483,391 · 6 Jul 2026
- SUS Autogrouper Software Re-Procurement · £800,000 · 1 Jul 2026
- Provision of: Amyloidosis Networked Model of Care · £5,040,000 · 29 Jun 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
- LW158 IMP Support (FAME) · Liverpool School of Tropical Medicine · £0
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.